They proposed an insulin adjustment protocol, increasing the basal insulin dose (glargine U100) by 20% daily if the average blood glucose was greater than 140 mg/dL and decreasing by 20% in case of hypoglycemia (<70 mg/dL). This evidence concerns the gene INS and Hypoglycemia.